The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
Xiang Yang Zhang
Institute of Mental Health
School of Medicine
Peking University
Beijing 100083
China
Name/email consistency: high
- Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. Zhang, X.Y., Zhou, D.F., Cao, L.Y., Zhang, P.Y., Wu, G.Y., Shen, Y.C. J. Clin. Psychiatry (2004)
- Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Zhang, X.Y., Zhou, D.F., Yuan, C.L., Zhang, P.Y., Wu, G.Y., Shen, Y.C. Psychiatry. Res (2002)
- Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Zhang, X.Y., Zhou, D.F., Zhang, P.Y., Wu, G.Y., Cao, L.Y., Shen, Y.C. Schizophr. Res. (2002)
- The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. Zhang, X.Y., Zhou, D.F., Su, J.M., Zhang, P.Y. J. Clin. Psychopharmacol (2001)
- Risperidone versus haloperidol in the treatment of acute exacerbations of chronic inpatients with schizophrenia: a randomized double-blind study. Zhang, X.Y., Zhou, D.F., Cao, L.Y., Zhang, P.Y., Wu, G.Y., Shen, Y.C. Int. Clin. Psychopharmacol (2001)
- A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. Zhang, X.Y., Zhou, D.F., Zhang, P.Y., Wu, G.Y., Su, J.M., Cao, L.Y. J. Clin. Psychiatry (2001)
